SeqOne Genomics

Montpellier, France

SeqOne is a next generation genomic analysis for next generation healthcare.

$22.6M raised

May 2025

Venture - Series Unknown

Analytics Big Data Biotechnology Health Care

Top Investors

BpifranceOmnes CapitalSupernova InvestMérieux Equity PartnersElaia

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SeqOne Genomics

How much funding has SeqOne Genomics raised?

SeqOne Genomics has raised $22.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2025.

Who are SeqOne Genomics's investors?

SeqOne Genomics's investors include Bpifrance, Omnes Capital, Supernova Invest, Mérieux Equity Partners, Elaia.

Where is SeqOne Genomics headquartered?

SeqOne Genomics is headquartered in Montpellier, France.

What does SeqOne Genomics do?

SeqOne is a next generation genomic analysis for next generation healthcare.

What stage is SeqOne Genomics at?

SeqOne Genomics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 22, 2025.

MLA

"SeqOne Genomics — Funding & Investors." VCBacked, May 22, 2025, https://www.vcbacked.co/company/seqone-genomics. Accessed June 4, 2026.

APA

VCBacked. (2025). SeqOne Genomics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/seqone-genomics

Wikipedia (cite web)

{{cite web |title=SeqOne Genomics — Funding & Investors |url=https://www.vcbacked.co/company/seqone-genomics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 22, 2025.

Similar Companies in Analytics